Serum parathyroid hormone levels predict coronary heart disease: The TromsãƒÂ¸ Study

European Journal of Preventive Cardiology

Volumn 11, Issue 1, 2004, Pages 69-74

  Kamycheva, Elena ^a   Sundsfjord, Johan ^a   Jorde, Rolf ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

calcium; cholesterol; coronary heart disease; diuretics; parathyroid hormone

Indexed keywords

CALCIUM; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; PARATHYROID HORMONE;

ADULT; AGE; AGED; ANAMNESIS; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE; BODY MASS; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NORWAY; PARATHYROID HORMONE BLOOD LEVEL; POPULATION RESEARCH; PREDICTION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SMOKING;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CALCIUM; CALCIUM, DIETARY; CORONARY DISEASE; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARATHYROID HORMONE; PREDICTIVE VALUE OF TESTS; SEX FACTORS; SYSTOLE;

EID: 1642385848     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000114706.27531.01     Document Type: Article

References (30)

1. Smith JC, Page MD, John R, Wheeler MH, Cockcroft JR, Scanlon MF, et al. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2000; 85: 3515–3519.
2. Neunteufl T, Katzenschlager R, Abela C, Kostner K, Niederle B, Weidinger F, et al. Impairment of endothelium-independent vasodilatation in patients with hypercalcemia. Cardiovasc Res 1998; 40: 396–401.
3. Piovesan A, Molineri N, Casasso F, Emmolo I, Ugliengo G, Cesario F. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol 1999; 50: 321–328.
4. Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 1993; 95: 197–202.
5. Rostand SG, Drüeke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 1999; 56: 383–392.
6. Jorde R, Sundsfjord J, Haug E, Bønaa KH. Relation between low calci m intake, parathyroid hormone, and blood pressure. Hypertension 2000; 35: 1154–1159.
7. Bro S, Olgaard K. Effects of excess PTH on nonclassical target organs. Am J Kidney Dis 1997; 30: 606–620.
8. Schlüter KD, Millar BC, McDermott BJ, Piper HM. Regulation of protein synthesis and degradation in adult ventricular cardiomyocytes. Am J Physiol 1995; 269: C1347–C1355.
9. Usdin TB, Bonner TI, Harta G, Mezey E. Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat. Endocrinology 1996; 137: 4285–4297.
10. Joborn H, Lundin L, Hvarfner A, Johahsson G, Wilde L, Ljunghall S. Serum electrolytes and parathyroid hormone in patients in a coronary care unit. J Intern Med 1989; 225: 9–14.
11. Herrmann G, Hehrmann R, Scholz HC, Atkinson M, Lichtlen P, von zur Mühlen A, et al. Parathyroid hormone in coronary artery disease – results of a prospective study. J Endocrinol Invest 1986; 9: 265–271.
12. Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Effects of thiazide- and loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study. J Intern Med 2001; 250: 144–153.
13. Bønaa KH, Arnesen E. Association between heart rate and atherogenic blood lipid fractions in a population: the Tromsø Study. Circulation 1992; 86: 394–405.
14. Jorde R, Bønaa KH. Calcium from dairy products, vitamin D intake, and blood pressure: the Tromsø study. Am J Clin Nutr 2000; 71: 1530–1535.
15. Altman DG. Relation between several variables. Analysis of survival times. In: Practical statistics for medical research, London: Chapman & Hall/CRC; 1999. pp. 351–358.
16. Kaplan RC, Heckbert SR, Furberg CD, Psaty BM. Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction. J Clin Epidemiol 2002; 55: 654–664.
17. Ljunghall S, Lundin L, Hvarfner A, Joborn H, Wide L. Serum electrolytes and parathyroid hormone concentrations in acute myocardial infarction. Exp Clin Endocrinol 1986; 88: 95–100.
18. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997; 96: 1755–1760.
19. Stefenelli T, Abela C, Frank H, Koller-Stramet Z, Clobits S, Bergler-Klein J. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab 1997; 82: 106–112.
20. Silverberg SJ. Cardiovascular disease in primary hyperparathyroidism. Clin Endocrinol Metab 2000; 85: 3513–3514.
21. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO4, Ca, Ca∗ PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131–2138.
22. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, Lundberg PA. Serum intact parathyroid hormone in a random population sample of men and women: relationship to anthropometry, life-style factors, blood pressure, and vitamin D. Calcif Tissue Int 1995; 56: 104–108.
23. Aksoy H, Akcay F, Kurtul N, Baykal O, Avci B. Serum 1, 25 dihydroxy vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy. Clin Biochem 2000; 33: 47–51.
24. Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 1990; 19: 559–563.
25. Arad Y, Spadaro LA, Roth M, Scordo J, Goodman K, Sherman S, et al. Serum concentration of calcium, 1, 25 vitamin D and parathyroid hormone are not correlated with coronary calcifications. An electron beam computed tomography study. Coron Artery Dis 1998; 9: 513–518.
26. Tian J, Smogorzewski M, Kedes L, Massry SG. Parathyroid hormone-parathyroid hormone related protein receptor messenger RNA is present in many tissues besides the kidney. Am J Nephrol 1993; 13: 210–213.
27. Schlüter K-D, Piper HM. Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovascular Res 1998; 37: 34–41.
28. Smogorzewski M. PTH, chronic renal failure and myocardium. Miner Electrolyte Metab 1995; 21: 55–62.
29. Nilsson IL, Aberg J, Rastad J, Lind L. Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 1999; 126: 1049–1055.
30. Brickman A, Nyby M, von Hungen K, Eggena P, Tuck M. Parathyroid hormone, platelet calcium, and blood pressure in normotensive subjects. Hypertension 1991; 18: 176–182.